Bexagliflozin found as effective as dapagliflozin for glycemic control in diabetes: Study Medha Baranwal11 April 2024 9:30 AM ISTChina: A 24-week, phase 3 trial has shed light on the safety and efficacy of bexagliflozin versus dapagliflozin as an adjunct to metformin in Chinese...
Pioglitazone add-on therapy in patients with type 2 diabetes effective and safe option for better glycemic control: Study Medha Baranwal10 April 2024 10:00 AM ISTSouth Korea: Adjunctive pioglitazone therapy in type 2 diabetes mellitus (T2DM) inadequately controlled with dapagliflozin and metformin yielded...
Exemed Pharmaceutical Gets CDSCO Panel Nod to Study Empagliflozin plus Glimepiride plus Metformin FDC Dr. Divya Colin7 April 2024 5:00 PM ISTNew Delhi: Exemed Pharmaceutical has got approval from the Subject Expert Committee SEC functional under the Central Drug Standard Control...
Evergreen Talk Series: How can Safety and Tolerability of Linagliptin and Dapagliflozin benefit diverse T2DM population? MD Brand Connect25 March 2024 4:38 PM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani, an...
Medical Bulletin 20/ March/ 2024 Anshika Mishra20 March 2024 3:00 PM ISTHere are the top medical news for the day:Even small dose of Liquorice can elevate blood pressure, finds studyAccording to a study conducted by...
Weight loss by diabetes drug linked to "anti-hunger" molecule, finds study Anshika Mishra19 March 2024 8:00 PM ISTResearchers from Stanford Medicine and Harvard Medical School have discovered an "anti-hunger" molecule that is produced after vigorous exercise is...
Metformin use in pregnancy influence offspring brain development: Study Anshika Mishra19 March 2024 7:30 PM ISTA study published in the Journal Molecular Metabolism revealed that although metformin has positive effects in pregnant mothers, it does not in the...
Insights from "EVER-Vilda", Expert Perspective on Vildagliptin's Applicability in Indian T2DM Patients MDTV Bureau14 March 2024 2:45 AM ISTThe "EVER-Vilda" opinion paper is an Indian expert's evaluation of the efficacy and rationality of vildagliptin. It underscores vildagliptin's...
Metformin combined with acupuncture knife therapy improves blood sugar, QoL in type 2 diabetes patients: Study Medha Baranwal13 March 2024 8:00 PM ISTChina: A recent study has shown improved clinical symptoms, blood glucose, and quality of life in type 2 diabetes (T2D) patients treated with...
Synokem Pharma Gets CDSCO Panel Nod To Study Antidiabetic FDC Dr. Divya Colin27 Feb 2024 6:00 PM ISTNew Delhi: The drug major Synokem Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Evergreen Talk Series: Combination of Linagliptin and Dapagliflozin in T2DM with multiple episodes of hypoglycemia MDTV Bureau21 Feb 2024 9:30 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani, an...
Lobeglitazone could be promising insulin sensitizer for management of type 2 diabetes in India: SENSITIZE INDIA trial Medha Baranwal18 Feb 2024 5:00 PM ISTIndia: Findings from a randomized, double-blind, phase III SENSITIZE INDIA trial have revealed the safety and efficacy of lobeglitazone 0.5 mg once...
